-2023 Balance by Quarter Change Topic Q2-23 Q1-23 Q2-22 Q2-23 VS Q1-23 Q2-23 VS Q2-22 (Million Baht: MB) (MB) % (MB) % Total revenue 1,703.0 1,296.7 1,711.8 406.3 31.3 (8.8) (0.5) Total operating expenses
operating expenses in Q1–2024 changed in line with and similar to the increase or decrease in revenue compared to Q1–2023. That is to say, the change rate in revenue for Q1–2024 increased by 29.9% and the
better understanding of climate risks so that they can combine their knowledge and relevant available information to enhance their capability to deal with climate change; (2) to make asset management
10.199% filed a letter requesting the company to hold extraordinary shareholders? meeting to consider the matters of (1) rights offering of newly issued shares and share warrants and (2) change of the
(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
Power Generation Others Total Change Increase (Decrease) Quarter 2 Quarter 2 Quarter 2 Quarter 2 2020 2019 2020 2019 2020 2019 Amount % Total Revenues 10,446 11,017 118 158 10,564 11,175 (611) (5%) Total
amortization Operating highlight in Q1/2018 Q1/17 Q4/17 Q1/18 Change +/(-) (THB million) QoQ YoY Operating revenue 5,366 4,849 5,716 18% 7% Gross profit 1,098 1,315 1,647 25% 50% EBITDA 915 1,137 1,482 30% 62
satisfactory operating performance, together with sound corporate governance, allowed KBank and K Companies to meet business targets, gaining wide acceptance and marks of recognition at home and abroad, as
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change